GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Quick Ratio

G.Barekat Pharm (XTEH:BRKT1) Quick Ratio : 0.84 (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. G.Barekat Pharm's quick ratio for the quarter that ended in Mar. 2017 was 0.84.

G.Barekat Pharm has a quick ratio of 0.84. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for G.Barekat Pharm's Quick Ratio or its related term are showing as below:

XTEH:BRKT1's Quick Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 3.53
* Ranked among companies with meaningful Quick Ratio only.

G.Barekat Pharm Quick Ratio Historical Data

The historical data trend for G.Barekat Pharm's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Quick Ratio Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Quick Ratio
- 0.84

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Quick Ratio - 0.84

Competitive Comparison of G.Barekat Pharm's Quick Ratio

For the Biotechnology subindustry, G.Barekat Pharm's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G.Barekat Pharm's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's Quick Ratio distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's Quick Ratio falls into.



G.Barekat Pharm Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

G.Barekat Pharm's Quick Ratio for the fiscal year that ended in Mar. 2017 is calculated as

Quick Ratio (A: Mar. 2017 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(26786837-6877322)/23783434
=0.84

G.Barekat Pharm's Quick Ratio for the quarter that ended in Mar. 2017 is calculated as

Quick Ratio (Q: Mar. 2017 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(26786837-6877322)/23783434
=0.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G.Barekat Pharm  (XTEH:BRKT1) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


G.Barekat Pharm Quick Ratio Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines